期刊文献+

间质性肺疾病中医证候与支气管肺泡灌洗液细胞学特征的研究 被引量:5

下载PDF
导出
摘要 目的:前瞻性研究ILD不同中医证候的支气管肺泡灌洗液(BALF)细胞学分类特征及与证候的相关性。方法:106例ILD患者四诊资料、BALF常规检查指标作为观察的内容。经过中医辨证分为气阴两虚证、气阴两虚夹瘀证、气虚血瘀证、气虚痰瘀互结证、气虚痰热瘀阻证,分别研究不同中医证候类型的BALF细胞活性和分类的特征以及与BALF细胞学特征相关关系。结果:五种中医证候均以嗜中性粒细胞增多、巨噬细胞减少为主要表现,其次表现为淋巴细胞增多。经统计分析发现五种中医证候BALF细胞活性、分类检测的巨噬细胞、淋巴细胞、嗜中性粒细胞含量存在显著差别(P<0.05)。结论:推测痰、热、瘀为主的虚实夹杂证细胞活性相应增强,以气阴两虚为主要证候细胞活性相对偏低;巨噬细胞、嗜中性粒细胞含量会导致痰热、痰瘀阻肺;淋巴细胞含量与ILD患者免疫系统失调相关。
出处 《中医药学报》 CAS 2014年第4期37-39,共3页 Acta Chinese Medicine and Pharmacology
基金 2009年度北京市中医药科技项目(JJ2009-23)
  • 相关文献

参考文献7

  • 1Raghu G, Collard HR, Egan JJ, et al. An Official TS/ERS/JRS/ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence - based Guidelines for Diagnosis and Management[ J]. Am J Respir Cfit Care Med ,2011, 183:788 -824.
  • 2王辰.中华医学会继续医学教育教材·呼吸学新进展[M].北京:中华医学电子音像出版社,2005:84-89.
  • 3国家技术监督局.中华人民共和国国家标准·中医临床诊疗术语(证候部分)[S].北京:中国标准出版社,1997.
  • 4朱元钰,蔡柏蔷,肖毅,等.当代呼吸病学进展[M].北京:中国协和医科大学出版社,2008:239.
  • 5盂淑燕.细胞凋亡与肺间质纤维化[J].国外医学·呼吸系统分册,2004,24(增刊)-38.
  • 6田德禄,单兆伟,黄衍寿.中医内科学[M].北京:人民卫生出版社,2007:24.
  • 7朱柠,陈小东.特发性肺纤维化的治疗进展[J].国际呼吸杂志,2007,27(9):668-672. 被引量:13

二级参考文献28

  • 1Kamp DW. Idiopathic pulmonary fibrosis: the inflammation hypothesis revisited. Chest, 2003,124 : 1187-1190.
  • 2Harold R, Collard, MD, Jay H, et al. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest, 2004,125 : 2169-2174.
  • 3Zisman DA, Lynch JP, Towes GB, et al. Cyclophodphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to cortisteroids. Chest, 2000,117 : 1619-1626.
  • 4Edan KB, Najib TA, Michael S, et al. Interferon-lb therapy in idiopathic pulmonary fibrosis. Chest, 2005,128 :203-206.
  • 5Plataki M, Koutsopoulos AV, Darivianaki BS, et al. Expressions of apoptic and antiapoptic makers in epithelial cells in idiopathic pulmonary fibrosis,Chest, 2005,127 : 266-274.
  • 6Naoki H, Kazuyoshi K, Mizuho Y, et al. Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice the. J Immunol, 2005,175 :1224-1231.
  • 7Fehrenbach H, Kasper M, Haase M, et al. Differential immunolocalization of VEGF in rat and human adult lung,and in experimental rat lung fibrosis: light, fluorescence,and electron microscopy. Anat Rec, 1999,254 : 61-73.
  • 8Marc hand AS,Marchal JI, Cohen M, et al. Defect of hepatocyte growth factor secretion by fibroblasts in idiopathic pulmonary fibrosis. Am J Res Crit Care Med,2003,168:1156-1161.
  • 9Carmel B, Keerthisingam RG, Jenkins, Nicholas K. et al. Cyclooxygenase-2 deficiency results in a loss of the anti- proliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis. Am J Pathol, 2001,158:1411-1422.
  • 10Bethany BM, Megan NB, Eric SW, et al. Bleomycin-Induced E prostanoid receptor changes alter fibroblast responses to prostaglandin E2. J Immunol, 2005,25 : 5644-5649.

共引文献52

同被引文献69

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部